NRX Pharmaceuticals, Inc. (NRXP): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2024-05-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Older than the company's other figures. The latest EPS (Diluted) is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$0.60
Year ended 2022-12-31
2020-12-31: -$1.512021-12-31: -$1.982022-12-31: -$0.60-$0.60
2020-12-31 EPS (Diluted) (USD per share) 2022-12-31
Period endedEPS (Diluted)Change YoYSource filing
2022-12-31-$0.60n/m2023-03-31, From 2022-01-01
2021-12-31-$1.98n/m2023-03-31, From 2021-01-01
2020-12-31-$1.51n/a2022-03-31, From 2020-01-01